| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |